BASF, Promega and Swiss TPH collaborate to drive research for malaria control
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
With an annual revenue of about $500 million, Spectrum will become part of the Industrial Solutions line of business within the Electronics & Industrial segment
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
Subscribe To Our Newsletter & Stay Updated